Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A modified Delphi consensus on tenosynovial giant cell tumour and giant cell tumour of bone : a report from the Birmingham Orthopaedic Oncology Meeting (BOOM).

The bone & joint journal·2026
Same author

Complications of PI to PIII hemipelvic resections for intermediate and malignant tumours : a systematic review and meta-analysis.

Bone & joint open·2026
Same author

Proximal humeral endoprosthetic reconstruction for tumour defects : clinical outcomes of 165 patients from the MUTARS Orthopedic Registry Orthopedic Registry Europe (MORE).

Bone & joint open·2025
Same author

Evaluating polyethylene, polyether-ether-ketone, and metal-on-metal locking mechanism survival in Modular Universal Tumour and Revision System knee reconstructions for oncological indications : insights from the MUTARS Orthopedic Registry Europe.

The bone & joint journal·2025
Same author

Controversies in orthopaedic oncology.

The bone & joint journal·2024
Same author

Navigation-Assisted Surgery for Locally Advanced Primary and Recurrent Rectal Cancer.

Annals of surgical oncology·2023

Related Experiment Video

Updated: Sep 21, 2025

Models of Bone Metastasis
08:49

Models of Bone Metastasis

Published on: September 4, 2012

42.4K

Megaprosthesis for Metastatic Bone Disease-A Comparative Analysis.

Joachim Thorkildsen1, Thale Asp Strøm1, Nils Jørgen Strøm2

  • 1Division of Orthopaedic Surgery, Oslo University Hospital, 0424 Oslo, Norway.

Current Oncology (Toronto, Ont.)
|May 27, 2022
PubMed
Summary

Revision surgery rates are lower for megaprosthetic reconstruction in metastatic bone disease (MBD) compared to primary bone sarcoma. This indicates better outcomes for MBD patients undergoing limb-sparing surgery.

Keywords:
complicationsmegaprosthesismetastatic bone diseaserevisionsarcomasurgery

More Related Videos

Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone
06:53

Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone

Published on: September 9, 2020

2.9K
A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
07:31

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

3.8K

Related Experiment Videos

Last Updated: Sep 21, 2025

Models of Bone Metastasis
08:49

Models of Bone Metastasis

Published on: September 4, 2012

42.4K
Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone
06:53

Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone

Published on: September 9, 2020

2.9K
A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
07:31

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

3.8K

Area of Science:

  • Orthopedic oncology
  • Musculoskeletal oncology
  • Limb reconstruction surgery

Background:

  • Megaprosthetic reconstruction is used for appendicular skeletal metastatic bone disease (MBD) with significant bone loss or segmental resection.
  • Previous studies focused on megaprosthetic outcomes in primary bone sarcoma, with high complication rates.
  • Outcomes for MBD after megaprosthetic reconstruction are not well-established.

Purpose of the Study:

  • To compare complication and revision surgery rates for MBD versus primary bone sarcoma treated with megaprosthetic reconstruction.
  • To analyze long-term outcomes using Kaplan-Meier and competing risk models.

Main Methods:

  • Comparative analysis of an institutional cohort from 2005-2019.
  • Descriptive data presentation and Kaplan-Meier (K-M) survival analysis.
  • Competing risk analysis accounting for death as a competing event.

Main Results:

  • Intermediate-term revision rates were significantly lower for MBD (8% at 1 year, 12% at 2 years) than for sarcoma (18% at 1 year, 24% at 2 years).
  • At 5 years, K-M analysis showed no significant difference, but competing risk analysis remained significant (8% for MBD vs. 20% for sarcoma).

Conclusions:

  • Megaprosthetic reconstruction for MBD demonstrates significantly lower revision surgery rates compared to primary bone sarcoma.
  • This suggests improved outcomes and implant survival for MBD patients undergoing this reconstructive procedure.